![Foto de Antonio](/img/nophoto.png)
Antonio
Verdejo García
Publicacións nas que colabora con Antonio Verdejo García (13)
2023
-
Intensive assessment of executive functions derived from performance in cognitive training games
iScience, Vol. 26, Núm. 6
2022
-
Endocannabinoid signaling of homeostatic status modulates functional connectivity in reward and salience networks
Psychopharmacology, Vol. 239, Núm. 5, pp. 1311-1319
2018
-
Cognitive and neuromodulation strategies for unhealthy eating and obesity: Systematic review and discussion of neurocognitive mechanisms
Neuroscience and Biobehavioral Reviews, Vol. 87, pp. 161-191
2014
-
Decision-making impairment predicts 3-month hair-indexed cocaine relapse
Psychopharmacology, Vol. 231, Núm. 21, pp. 4179-4187
-
Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers
Journal of Psychopharmacology, Vol. 28, Núm. 12, pp. 1170-1177
-
Functional alteration in frontolimbic systems relevant to moral judgment in cocaine-dependent subjects
Addiction Biology, Vol. 19, Núm. 2, pp. 272-281
2013
-
COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users
Neuropsychopharmacology, Vol. 38, Núm. 8, pp. 1598-1606
-
Genetics of Ecstasy (MDMA) Use
Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders (Elsevier), pp. 441-451
-
Genetics of Ecstasy (MDMA) Use
Biological Research on Addiction (Elsevier Inc.), pp. 441-451
2011
-
The influence of genetic and environmental factors among MDMA users in cognitive performance
PLoS ONE, Vol. 6, Núm. 11
2010
-
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users
Journal of Psychopharmacology, Vol. 24, Núm. 9, pp. 1381-1393
2008
-
Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: Evidence from a 12-month longitudinal study
Psychopharmacology, Vol. 200, Núm. 3, pp. 425-437
-
Cognitive performance in recreational ecstasy polydrug users: A two-year follow-up study
Journal of Psychopharmacology, Vol. 22, Núm. 5, pp. 498-510